Please login to the form below

Not currently logged in
Email:
Password:

Valeant adds member to board of directors

President of ValueAct Capital G. Mason Morfitadded to team
Valeant Mason Morfit

Valeant Pharmaceuticals has added G. Mason Morfit, president of ValueAct Capital to its board of directors, effective immediately.

Morfit also currently serves on the board of directors for Microsoft and was former director of CR Bard, Immucor, Advanced Medical Optics and Solexa prior to his role at ValueAct Capital.

Morfit had originally served on Valeant's board of directors between 2007 and 2014.

Michael Pearson, chairman and CEO of Valeant, said: “I am pleased to welcome Mason back to the Valeant board of directors.

“Although Mason has not officially been a part of the Valeant board for more than a year, I have continued to value his vision and guidance, and I believe his insights will be invaluable during this time.”

26th October 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics